Bajaj Anurag, Pancholy Samir, Sothwal Arpit, Nawaz Yassir, Boruah Pranjal
Department of Cardiology, The Wright Center for Graduate Medical Education, 111 North Washington Avenue, Scranton, PA 18503, USA.
Department of Medicine, Geisinger Common Wealth School of Medicine, 525 Pine Street, Scranton, PA 18510, USA.
Cardiovasc Revasc Med. 2019 Sep;20(9):790-798. doi: 10.1016/j.carrev.2018.10.025. Epub 2018 Nov 3.
PCI of ULMS is frequently performed through TFA because of technical complexity and safety concern. Studies have shown comparable efficacy and safety of TRA versus TFA, however, these studies are few in number. We intended to compare the clinical outcomes between transradial access (TRA) and transfemoral access (TFA) in patients undergoing percutaneous coronary intervention (PCI) for unprotected left main coronary artery stenosis (ULMS) by performing a meta-analysis.
A systematic search of database, including, PubMed, Web of Science, Google scholar and Cochrane Database were performed by two independent reviewers. Studies were included comparing "TRA" versus "TFA" in patients undergoing PCI in ULMS. The primary outcome was a procedural success rate. Secondary outcomes were major bleeding, access site complications, in-hospital and long term: major adverse cardiac events (MACE), myocardial infarction (MI) and cardiovascular mortality.
Eight studies were included in the analysis. The procedural success rate was 97.3% and there was no statistically significant difference between TRA and TFA groups (OR, 1.41 [CI 0.64, 3.12], I = 26%). The rates of access site complications (OR, 0.17 [CI 0.07, 0.41], I = 16%), major bleeding (OR, 0.39 [CI 0.17, 0.86], I = 0%) and all-cause mortality (OR, 0.28 [CI 0.12, 0.64], I = 0%) were lower in the TRA group. There were no significant differences in in-hospital and long term cardiovascular mortality, MI and MACE between the two groups.
In contrast to TFA, TRA is associated with reduced bleeding and access site complications, with similar procedural success rate in patients undergoing PCI of ULMS.
由于技术复杂性和安全性问题,无保护左主干(ULMS)的经皮冠状动脉介入治疗(PCI)通常通过股动脉途径(TFA)进行。研究表明,经桡动脉途径(TRA)与TFA的疗效和安全性相当,然而,此类研究数量较少。我们旨在通过进行一项荟萃分析,比较接受无保护左主干冠状动脉狭窄(ULMS)经皮冠状动脉介入治疗(PCI)患者的经桡动脉入路(TRA)和经股动脉入路(TFA)的临床结局。
由两名独立审阅者对包括PubMed、科学网、谷歌学术和考克兰数据库在内的数据库进行系统检索。纳入比较ULMS患者PCI中“TRA”与“TFA”的研究。主要结局为手术成功率。次要结局为大出血、穿刺部位并发症、住院期间及长期:主要不良心脏事件(MACE)、心肌梗死(MI)和心血管死亡率。
八项研究纳入分析。手术成功率为97.3%,TRA组和TFA组之间无统计学显著差异(比值比,1.41 [可信区间0.64, 3.12],I² = 26%)。TRA组的穿刺部位并发症发生率(比值比,0.17 [可信区间0.07, 0.41],I² = 16%)、大出血发生率(比值比,0.39 [可信区间0.17, 0.86],I² = 0%)和全因死亡率(比值比,0.28 [可信区间0.12, 0.64],I² = 0%)较低。两组在住院期间及长期心血管死亡率、MI和MACE方面无显著差异。
与TFA相比,TRA与出血和穿刺部位并发症减少相关,在接受ULMS PCI的患者中手术成功率相似。